Phase 2 clinical trial results of a COVID-19 vaccine developed by Medigen Vaccine Biologics Corp generated good data, experts said, although they warned that there was still no way to know how effectively it would prevent the disease.
“Data look quite good,” Academia Sinica researcher Michael Lai (賴明詔) said on Thursday after Medigen announced that its vaccine candidate had shown no major safety concerns.
The data showed that the vaccine produced sufficient neutralizing antibodies and as long as there were antibodies, there should be protection, Lai said, adding that its toxicity was low.
Photo: Tsai Wen-chu, Taipei Times
The Medigen vaccine has achieved the goals of creating sufficient neutralizing antibodies and having low toxicity, but only phase 3 trials could determine if it actually protects people who receive it, said Lai, who is a virologist and a coronavirus researcher.
There are many ways to produce vaccines, including via protein subunits such as the one Medigen is working on, he said.
The most traditional way is to use the virus to produce a vaccine with several proteins that the immune system recognizes should not be there, triggering an immune response, he said.
However, this method can produce a level of toxicity, he said.
A protein subunit vaccine has only one protein, in this case a spike protein, he said.
“It is purer, but could trigger a weaker immune reaction,” Lai said. “Different vaccine production methods have different advantages and disadvantages. One cannot be compared to another.”
It could take several years for a domestic vaccine to go through phase 3 trials, so given Taiwan’s situation, “it should opt for second-best,” even though major vaccines made elsewhere in a matter of months obtained enough efficacy data in phase 3 trials to get emergency use authorization (EUA), he said.
It would be acceptable for Medigen to apply for EUA with only the results of its phase 2 trials, he said.
National Taiwan University Hospital pediatrician Lu Chun-yi (呂俊毅), who is secretary-general of the Taiwan Immunization Vision and Strategy organization, said that the Medigen data were “good.”
Almost every participant had antibodies after being inoculated and the antibody concentration data were promising, Lu said.
However, there is no international consensus on how high the geometric mean titer (GMT) — or antibody concentration — has to be to indicate sufficient protection, he said.
Moreover, no uniform, globally accepted method for verifying antibody concentrations exists, meaning that vaccines have a wide range of GMTs, from as low as just over 100 to above 3,000, he said.
Different laboratories conduct trials with different materials and methods, leading to results that vary across labs, Lu said.
Shih Shin-ru (施信如), who heads the Research Center for Emerging Viral Infections at Chang Gung University said that it was still too early to say whether Medigen had successfully developed a COVID-19 vaccine, because nobody knows how high the neutralizing antibody concentration needs to be.
Medigen said it would seek an EUA from the Food and Drug Administration as soon as possible based on the promising results from its phase 2 clinical trials.
It would also apply to the European Medicines Agency and other international health authorities to begin phase 3 clinical trials as soon as possible, it said.
A decision to describe a Chinese Ministry of Foreign Affairs statement on Singapore’s Taiwan policy as “erroneous” was made because the city-state has its own “one China policy” and has not followed Beijing’s “one China principle,” Deputy Minister of Foreign Affairs Tien Chung-kwang (田中光) said yesterday. It has been a longstanding practice for the People’s Republic of China (PRC) to speak on other countries’ behalf concerning Taiwan, Tien said. The latest example was a statement issued by the PRC after a meeting between Singaporean Prime Minister Lawrence Wong (黃循財) and Chinese President Xi Jinping (習近平) on the sidelines of the APEC summit
Taiwan’s passport ranked 34th in the world, with access to 141 visa-free destinations, according to the latest update to the Henley Passport Index released today. The index put together by Henley & Partners ranks 199 passports globally based on the number of destinations holders can access without a visa out of 227, and is updated monthly. The 141 visa-free destinations for Taiwanese passport holders are a slight decrease from last year, when holders had access to 145 destinations. Botswana and Columbia are among the countries that have recently ended visa-free status for Taiwanese after “bowing to pressure from the Chinese government,” the Ministry
‘SIGN OF DANGER’: Beijing has never directly named Taiwanese leaders before, so China is saying that its actions are aimed at the DPP, a foundation official said National Security Bureau (NSB) Director-General Tsai Ming-yen (蔡明彥) yesterday accused Beijing of spreading propaganda, saying that Chinese President Xi Jinping (習近平) had singled out President William Lai (賴清德) in his meeting with US President Joe Biden when talking about those whose “true nature” seek Taiwanese independence. The Biden-Xi meeting took place on the sidelines of the APEC summit in Peru on Saturday. “If the US cares about maintaining peace across the Taiwan Strait, it is crucial that it sees clearly the true nature of Lai and the ruling Democratic Progressive Party (DPP) in seeking Taiwanese independence, handles the Taiwan question with extra
HEALTHCARE: Following a 2022 Constitutional Court ruling, Taiwanese traveling overseas for six months would no longer be able to suspend their insurance Measures allowing people to suspend National Health Insurance (NHI) services if they plan to leave the country for six months would be abolished starting Dec. 23, NHIA Director-General Shih Chung-liang (石崇良) said yesterday. The decision followed the Constitutional Court’s ruling in 2022 that the regulation was unconstitutional and that it would invalidate the regulation automatically unless the NHIA amended it to conform with the Constitution. The agency would amend the regulations to remove the articles and sections that allow the suspension of NHI services, and also introduce provisional clauses for those who suspended their NHI services before Dec. 23, Shih said. According to
RSS